The Trump administration rolled out its new prescription drug platform — TrumpRx — with the promise of saving Americans money.

But congressional Democrats have a new warning: The website directs Americans to brand-name drugs rather than generics, meaning consumers are frequently at risk of paying more than they should — in some cases, thousands of dollars annually.

In a new report shared first with MS NOW, Democrats on the Joint Economic Committee analyzed the prices of 15 common medications, comparing the discounted prices on the TrumpRx website to the cost of generics purchased using a GoodRx coupon.

The report shows, for instance, that a year’s supply of the atrial fibrillation medication Tikosyn, purchased at the TrumpRx discounted rate, would cost about $4,000. By contrast, according to the report, a generic version of the drug bought with a GoodRx coupon would cost just shy of $200 annually — a savings of roughly $3,800. (The report uses Manchester, N.H., as the location for the GoodRx search.),,,,,

Health care and consumer prices are primed to be a point of contention heading into the fall midterm elections.

Trump has touted the website and his negotiations with drug companies as part of his work to lower costs. Democrats, meanwhile, have accused Republicans of only making matters worse, pointing to the expiration of enhanced Affordable Care Act subsidies at the start of 2026 as a prime example.